Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      Homedrug manufacturers

      drug manufacturers

      The EC has approved J&J’s Tecvayli for the treatment of multiple myeloma.
      Investing News

      The EC has approved J&J’s Tecvayli for the treatment of multiple myeloma.

      August 25, 2022
      Annovis Bio’s Phase III Dosing Begins for Parkinson’s Study
      Investing News

      Annovis Bio’s Phase III Dosing Begins for Parkinson’s Study

      August 25, 2022
      The FDA has approved the Novavax COVID-19 vaccine for use in adolescents.
      Investing News

      The FDA has approved the Novavax COVID-19 vaccine for use in adolescents.

      August 22, 2022
      Pfizer requests that the FDA approve Covid booster injections that target omicron BA.5 for individuals aged 12 and up
      Investing News

      Pfizer requests that the FDA approve Covid booster injections that target omicron BA.5 for individuals aged 12 and up

      August 22, 2022
      Quest Diagnostics Finds The Missing Piece Of The New Alzheimer’s Therapy Package
      Uncategorized

      Quest Diagnostics Finds The Missing Piece Of The New Alzheimer’s Therapy Package

      July 6, 2022
      Nirvana Life Sciences Inc. Announces License for a Delivery System for Psychedelic APIs
      Other

      Nirvana Life Sciences Inc. Announces License for a Delivery System for Psychedelic APIs

      July 6, 2022
      Compugen to Present at Upcoming Industry Conferences
      Health

      Compugen to Present at Upcoming Industry Conferences

      June 27, 2022
      « 1 2 3 4

       

      LATEST NEWS

      • Investing News Beta Technologies Q3 IPO Insights
      • Investing News Salesforce Reports Robust Q3 2026 Earnings
      • Investing News Salesforce’s Stock Boost Amid Raised Guidance
      • Investing News Macy’s Q3 2025 Earnings Overview
      • Investing News Okta’s Strong Q3 2026 Earnings Boost Shares

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2025